Astec Lifesciences Ltd

Price Movement Clarification

Astec Lifesciences Price Movement Clarification

Astec LifeSciences responded to an NSE surveillance query on volume spurt. The company confirmed no developments requiring mandatory disclosure under LODR or PIT Regulations.

Debt & Borrowing

Astec Lifesciences Debt & Borrowing: ₹25 Cr

Astec LifeSciences Limited has confirmed the timely payment of the maturity amount for its commercial paper. The redemption amount totals ₹25 Crore.

Value

₹25.00 Cr

Price Movement Clarification

Astec Lifesciences Price Movement Clarification

Astec LifeSciences replied to an NSE volume-spike surveillance notice, confirming full disclosure compliance. No undisclosed developments exist under Listing or PIT Regulations.

Financial Results

Astec Lifesciences Q1 FY27 Results: Net Loss of ₹18.7 Cr, Loss Narrows

Astec Lifesciences Ltd reported revenue from operations of ₹83.6 Cr (-8.2% YoY) and a net loss of ₹18.7 Cr for Q1 FY27.

Key figure

Net loss ₹18.7 Cr

Financial Results

Astec Lifesciences Q4 FY26 Results: Net Loss of ₹7.5 Cr, Loss Narrows

Astec Lifesciences Ltd reported revenue from operations of ₹158.6 Cr (+32.7% YoY) and a net loss of ₹7.5 Cr for Q4 FY26.

Key figure

Net loss ₹7.5 Cr